Review
Published on 31 Oct 2022
Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2022.1028728
- 4,284 views
- 7 citations





